Upstream Bio (UPB) Accumulated Depreciation (2023 - 2026)

Upstream Bio's Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $393000.0 for Q1 2026.

• On a quarterly basis, Accumulated Depreciation rose 97.49% year-over-year to $393000.0 in Q1 2026; TTM through Mar 2026 was $393000.0, a 97.49% increase from a year earlier, with the FY2025 full-year figure at $344000.0, up 120.51% from the prior year.
• Accumulated Depreciation improved to $393000.0 in Q1 2026 per UPB's latest filing, from $344000.0 in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $393000.0 in Q1 2026 and bottomed at $67000.0 in Q4 2023.
• The 4-year median for Accumulated Depreciation is $220000.0 (2025), against an average of $224250.0.
• Across the five-year window, Accumulated Depreciation soared 168.22% in 2025 and jumped 97.49% in 2026, its largest moves.
• Year by year, Accumulated Depreciation stood at $67000.0 in 2023, then surged by 132.84% to $156000.0 in 2024, then surged by 120.51% to $344000.0 in 2025, then climbed by 14.24% to $393000.0 in 2026.
• Per Business Quant, the three latest UPB Accumulated Depreciation figures stand at $393000.0 (Q1 2026), $344000.0 (Q4 2025), and $287000.0 (Q3 2025).